Tizanidine Should Not Be Used for Primary Insomnia
Tizanidine is not indicated or recommended for sleep disorders, and you should not prescribe it for this purpose. The American Academy of Sleep Medicine clinical practice guideline for chronic insomnia does not include tizanidine among recommended treatments 1. The FDA-approved indication for tizanidine is spasticity management, not sleep 2.
Why Tizanidine Is Not Appropriate for Sleep
Lack of Evidence-Based Support
- The 2017 AASM guideline explicitly recommends against using medications without proven efficacy for insomnia 1
- Tizanidine is FDA-approved only for spasticity at doses of 4-36 mg daily, divided into 2-3 doses 2
- No controlled trials support its use as a primary sleep aid in otherwise healthy adults
Safety Concerns
- QT prolongation risk: Tizanidine blocks the IKr cardiac channel and can prolong the QT interval, potentially causing cardiac arrhythmias 3
- Significant hypotensive effects, with diastolic blood pressure dropping 13% and systolic 10% 4
- Peak sedative effects occur 1-2 hours after dosing but dissipate within 3-6 hours 2, making it poorly suited for sleep maintenance
- Complex food interactions that significantly alter drug absorption and timing of effects 2
What You Should Use Instead
For sleep onset insomnia, the AASM guideline suggests:
- Zolpidem 10 mg
- Zaleplon 10 mg
- Triazolam 0.25 mg
- Ramelteon 8 mg 1
For sleep maintenance insomnia, consider:
- Eszopiclone 2-3 mg
- Temazepam 15 mg
- Doxepin 3-6 mg 1
The Only Exception: Spasticity-Related Sleep Disturbance
If your patient has documented spasticity (cerebral palsy, spinal cord injury, multiple sclerosis) causing sleep disruption due to muscle pain and hypertonicity, then tizanidine may be appropriate:
- Start with 2-4 mg at bedtime 2
- In pediatric spasticity cases, doses of 0.1-0.2 mg/kg/day have shown benefit for sleep disturbance secondary to spasticity 5
- One study in palliative care patients with chronic muscle pain reported that nighttime dosing improved sleep onset without morning hangover 6
Critical caveat: Even in these cases, you are treating the underlying spasticity that disrupts sleep, not primary insomnia. The sedation is a side effect being leveraged therapeutically, not the primary mechanism 2.
Common Pitfall to Avoid
Do not prescribe tizanidine off-label for sleep simply because it causes drowsiness. The sedative effect is dose-dependent and unpredictable 4, and the drug carries cardiovascular risks that are unjustifiable when evidence-based alternatives exist 3. The fact that 79.3% of children with cerebral palsy tolerated it well 7 does not translate to appropriateness for primary insomnia in adults without spasticity.